These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37566876)

  • 1. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
    Lee Y; Choi S; Kim HS
    Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.
    Kim H; Na K; Bae GE; Kim HS
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
    Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
    Miyama Y; Ogasawara A; Hasegawa K; Yasuda M
    Int J Gynecol Pathol; 2024 Jul; 43(4):362-372. PubMed ID: 38870078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
    Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
    Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
    Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
    Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma.
    Park S; Bae GE; Kim J; Kim HS
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma.
    Patel V; Kipp B; Schoolmeester JK
    Hum Pathol; 2019 Apr; 86():243-248. PubMed ID: 30172914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
    Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
    Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
    Choi KH; Kim H; Bae GE; Lee SH; Woo HY; Kim HS
    Anticancer Res; 2021 Sep; 41(9):4587-4601. PubMed ID: 34475087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas.
    McFarland M; Quick CM; McCluggage WG
    Histopathology; 2016 Jun; 68(7):1013-20. PubMed ID: 26484981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
    Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
    Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL; McBride HA; Jamison J; McCluggage WG
    Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial Mesonephric-like Adenocarcinoma Presenting as an Ocular Lesion: A Case Report.
    Al Nabhani S; Doyle A; Kennedy S; McVey R; Crown J; Gibbons D
    Int J Gynecol Pathol; 2022 Mar; 41(2):161-167. PubMed ID: 33935158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
    Ji N; Lee Y; Lee SH; Kim HS
    Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma.
    Chibbar R; Foerstner S; Suresh J; Chibbar R; Piche A; Kundapur D; Kanthan R; Kundapur V; Lee CH; Agrawal A; Lai R
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):181-188. PubMed ID: 36695555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
    Roma AA; Goyal A; Yang B
    Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry.
    Tahir M; Xing D; Ding Q; Wang Y; Singh K; Suarez AA; Parwani A; Li Z
    Histopathology; 2025 Jan; 86(2):268-277. PubMed ID: 39233315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.